Weight Loss

overweight woman measures her waist

Why America’s Obesity Crisis Is Complicated

While obesity rates have fallen in some U.S. States, researchers warn that current definitions don't paint a full picture of America's weight crisis.

WeightWatchers, Amazon Team Up for Fast-Tracked Weight-Loss Meds

WeightWatchers has teamed with Amazon Pharmacy to simplify access to GLP-1 weight-loss drugs with real-time stock updates and home delivery.

America’s Obesity Crisis Is Much Worse Than You Think, Researchers Warn

Under a new definition of obesity endorsed by the The American Heart Association, 70% of Americans are obese, up from 40% currently.

Kevin Hart’s VC Firm Leads $35M Round for AI Weight Loss App

The AI-powered Simple Life app ditches calorie counting in favor of data-driven coaching, gamification and habit science.

woman leg presses with her personal trainer

Personal Trainers Say Their Jobs Are Changing Due to the Rise of GLP-1s

NASM's new survey of 500 fitness pros shows GLP-1 drugs like Ozempic are reshaping the industry and the role of personal trainers.

Wearables Uncover Hidden Insights Into Overeating in New Study

A necklace, wristband and bodycam helped researchers reveal five hidden overeating styles that could shape the future of obesity treatment.

Rebel Wilson

Rebel Wilson, Noom Partner as GLP-1s Enter Microdose Era

Rebel Wilson joins Noom as chief wellness ambassador, backing its new free tier that gamifies healthy habits and spotlights microdose GLP-1s.

tablet shoes people exercising in an Apple Fitness+ class

Apple Fitness+ Partners With GLP-1 Provider FuturHealth

FuturHealth, a provider of weight-loss solutions including GLP-1s, will offer Apple Fitness+ at no additional cost to its members.

A woman sitting at desk by a fruit bowl and a computer.

GLP-1s Opened the Door, Hims & Hers Says Personalization Holds the Key

Hims & Hers' Dr. Craig Primack explains why personalized care, not just GLP-1s, is the key to lasting weight loss success.

A scale.

Syntis Bio Secures $38M for Weight Loss Pill That Mimics Gastric Bypass Surgery

Syntis Bio has raised $38M to advance its injectable-free, once-daily pill that mimics gastric bypass surgery.